Home / mesothelioma / mesothelioma law firm / Lilly, Incyte rheumatoid arthritis drug succeeds in late

Tuesday, September 29, 2015

Lilly, Incyte rheumatoid arthritis drug succeeds in late

By Unknown
On

ReutersLilly, Incyte rheumatoid arthritis drug succeeds in late-stage studyReutersEli Lilly and Co and Incyte Corp said a third late-stage study of their experimental rheumatoid arthritis drug met its main goal. The drug, baricitinib, was more effective than the decades-old treatment methotrexate, after 24 weeks of treatment, in ...Baricitinib Superior to Methotrexate in Reducing Signs and Symptoms in Pivotal ...MarketWatchall 4 news articles »

Lilly, Incyte rheumatoid arthritis drug succeeds in late Rating: 4.5 Diposkan Oleh: Unknown

Subscribe to: Post Comments (Atom)
 

Top